CAKE by Accelerize Boosts Lead Generation Program for Prominent Performance Marketing Network in Healthcare

Patient’s Guide Sees Surge in Delivery Speeds by +75%, Monetization per Lead by +50%, Reduces Client Onboarding Time by 400% with CAKE Implementation

NEWPORT BEACH, Calif. – June 12, 2015 – Accelerize (OTCQB: ACLZ) (OTCBB: ACLZ) and its digital marketing software division CAKE, today announced that Patient’s Guide, a leading performance marketing and lead generation network in healthcare, is using CAKE to track, attribute and optimize lead-generation campaigns for its growing client base. After implementing the CAKE SaaS solution as its primary marketing performance platform, the Patient’s Guide is driving improvements in time to value, improving the patient and client experience, as well as making strides to consistently match lead buyers with the sellers who deliver the best results.

With over two million monthly visitors and 20,000 connected patients monthly, Patient’s Guide helps medical practitioners, pharmaceutical and medical device companies reach their ideal customer at the opportune moment. Prior to using CAKE, the organization’s lead generation program was partly programmatic but largely a manual process. From routing leads to accounting, this method required substantial human resources. In addition, after onboarding a client, Patient’s Guide required up to five days to build out code to connect its system to their API for lead transmission. After implementing CAKE, that process is completely automated. Not only did it streamline the entire flow – from the moment the lead is generated to the reporting dashboard – it minimized errors and provided greater capability to monetize each lead.

“CAKE has transformed our lead generation program,” said Jasson Gilmore, CEO of Patient’s Guide. “The marketing platform has allowed us to streamline our process to deliver quality leads, while also significantly reducing our costs and management time regarding logistics and reporting. As a result, we can focus on other vital aspects of our business – provide a better service, dedicate more time to our clients and ultimately, increase profitability. It’s hard to imagine working without CAKE.”

Marketers in the US healthcare and pharmaceutical industry will invest $1.64 billion in digital advertising in 2015. By 2019, eMarketer expects total digital spending will reach $2.55 billion. New products and more sophisticated data targeting are fueling growth, especially in mobile, video and native formats.

“Healthcare is a rapidly growing segment for digital marketing,” said Santi Pierini, CAKE President and Chief Operating Officer of Accelerize. “And as the demand for data-driven insight continues its upward growth trajectory, performance marketing is steadily becoming integral to the overall media mix. Enterprises across all industries, including healthcare organizations such as Patient’s Guide, trust CAKE to accurately track the performance of their digital marketing dollars. Patient’s Guide user base is growing at an incredible rate and we are pleased that CAKE is helping uplift its lead generation program to the next level.”

About Patient’s Guide

Patient’s Guide (PG) is one of the largest performance marketing networks in healthcare, reaching over two million consumers every month across numerous sites like www.wrinkles.org, hairremovaljournal.org, and many others. PG helps health practitioners, medical device and pharma companies reach their target demographic at the best possible ROI.

About CAKE by Accelerize

CAKE, a division of Accelerize Inc., provides a SaaS-based solution to track, attribute and optimize the performance of digital marketing spend, in real-time. Bringing clarity to multi-channel marketing campaigns, we empower advertisers, agencies, publishers and networks with the insight to make intelligent marketing decisions. For more information, visit www.getCAKE.com.

About Accelerize

Accelerize Inc. (OTCQB: ACLZ) (OTCBB: ACLZ) offers marketing technology solutions that revolutionize the way advertisers leverage their digital advertising data. For more information, visit www.accelerize.com.

Use of Forward-looking Statements

This press release may contain forward-looking statements from Accelerize Inc. within the meaning of the “safe harbor” provisions of the Private Securities Litigation Reform Act of 1995 and federal securities laws. For example, when Accelerize describes the market for digital advertising and its growth potential, and uses other statements containing the words “believes,” “anticipates,” “plans,” “expects,” “will” and similar expressions, Accelerize is using forward-looking statements. These forward-looking statements are based on the current expectations of the management of Accelerize only, and are subject to a number of factors and uncertainties that could cause actual results to differ materially from those described in the forward-looking statements. The following factors, among others, could cause actual results to differ materially from those described in the forward-looking statements: changes in technology and market requirements; our technology may not be validated as we progress further; we may be unable to retain or attract key employees whose knowledge is essential to the development of our products and services; unforeseen market and technological difficulties may develop with our products and services; inability to timely develop and introduce new technologies, products and applications; or, loss of market share and pressure on pricing resulting from competition, which could cause the actual results or performance of Accelerize to differ materially from those contemplated in such forward-looking statements. Except as otherwise required by law, Accelerize undertakes no obligation to publicly release any revisions to these forward-looking statements to reflect events or circumstances after the date hereof or to reflect the occurrence of unanticipated events. For a more detailed description of the risk and uncertainties affecting Accelerize, reference is made to Accelerize’s reports filed from time to time with the Securities and Exchange Commission.

Leave a Reply

Your email address will not be published. Required fields are marked *